Defining Endocytic Pathways of Fucoidan-Coated PIBCA Nanoparticles from the Design of their Surface Architecture

Abstract

Purpose This work investigated the endocytic pathways taken by poly(isobutylcyanoacrylate) (PIBCA) nanoparticles differing in their surface composition and architecture, assuming that this might determine their efficiency of intracellular drug delivery. Methods Nanoparticles (A0, A25, A100, R0, R25 ) were prepared by anionic or redox radical emulsion polymerization using mixtures of dextran and fucoidan (0, 25, 100 % in fucoidan). Cell uptake was evaluated by incubating J774A.1 macrophages with nanoparticles. Endocytic pathways were studied by incubating cells with endocytic pathway inhibitors (chlorpromazine, genistein, cytochalasin D, methyl-ß-cyclodextrin and nocodazole) and nanoparticle uptake was evaluated by flow cytometry and confocal microscopy. Results The fucoidan-coated PIBCA nanoparticles A 25 were internalized 3-fold more efficiently than R 25 due to the different architecture of the fucoidan chains presented on the surface. Different fucoidan density and architecture led to different internalization pathway preferred by the cells. Large A 100 nanoparticles with surface was covered with fucoidan chains in a loop and train configuration were internalized the most efficiently, 47-fold compared with A 0 , and 3-fold compared with R 0 and R 25 through non-endocytic energy-independent pathways and reached the cell cytoplasm. Conclusion Internalization pathways of PIBCA nanoparticles by J774A.1 macrophages could be determined by nanoparticle fucoidan surface composition and architecture. In turn, this influenced the extent of internalization and localization of accumulated nanoparticles within cells. The results are of interest for rationalizing the design of nanoparticles for potential cytoplamic drug delivery by controlling the nature of the nanoparticle surface. Graphical abstract Supplementary Information The online version contains supplementary material available at 10.1007/s11095-022-03202-4.

Glucose oxidase and conjugated polymer nanocomplexes for synergistic photothermal/starvation/oxidation therapy

“…S11A (ESI†), cervical cancer HeLa cells exhibited obvious red fluorescence, and the endocytosis of IBDDP&GOx NPs increased as time went and the temperature increased from 4 to 37 ° C. To explain the specific endocytic pathway of the NPs in detail, HeLa cells were pretreated with a series of inhibitors: amiloride (micropinocytosis), glucose (clathrin-mediated), genistein (caveolin-mediated) and Na 3 N (energy-dependent) and analyzed by FCM for the endocytosis ability of the NPs. 37–39 The fluorescence intensity of IBDDP&GOx NPs significantly decreased after glucose, genistein and Na 3 N treatment, indicating that the nanoparticles were mainly endocytosed into tumor cells in an energy-dependent clathrin- and caveolin-mediated manner (Fig. S11B , ESI†).…”

NOAEL cancer therapy: a tumor targetable docetaxel–inorganic polymer nanohybrid prevents drug-induced neutropenia

“…In addition, the cellular internalization of PTX-Cy5.5 was investigated after pre-treatment with endocytosis inhibitors. 21,22 for 1 h, such as CPZ 23 and K + depletion 24 (clathrin-mediated endocytosis inhibitors), genistein (a caveolae-mediated endocytosis inhibitor), 25 and amiloride (a micropinocytosis inhibitor), 26 respectively. As seen in Fig.…”

Nanotubes from bacteriophage tail sheath proteins: internalisation by cancer cells and macrophages

“…39 Pinocytosis could also be used for the 053SNAP entry into HCT116 cells, as it can be dynamin-dependent and several studies report the uptake of various nanoparticles by pinocytosis. 40,41 Clearance of 053SNAP nanotubes by peritoneal macrophages…”